Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Localized PD-1 Blockade in a Mouse Model of Renal Cell Carcinoma. | Front Drug Deliv | 2022 | 36132332 | PubTator, text mining | PubMed |
| STMN1 as a novel prognostic biomarker in HCC correlating with immune infiltrates and methylation. | World J Surg Oncol | 2022 | 36127700 | PubTator, text mining | PubMed |
| Systematic Characterization of Expression Patterns and Immunocorrelations of Formin-Like Genes in Breast Cancer. | Biomed Res Int | 2022 | 36124068 | PubTator, text mining | PubMed |
| RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma. | Front Pharmacol | 2022 | 36120364 | PubTator, text mining | PubMed |
| Integrated analysis of immune parameters, miRNA-mRNA interaction, and immune genes expression in the liver of rainbow trout following infectious hematopoietic necrosis virus infection. | Front Immunol | 2022 | 36119061 | PubTator, text mining | PubMed |
| CSTF2 Acts as a Prognostic Marker Correlated with Immune Infiltration in Hepatocellular Carcinoma. | Cancer Manag Res | 2022 | 36117731 | PubTator, text mining | PubMed |
| Keratinocyte-derived cytokine TSLP promotes growth and metastasis of melanoma by regulating the tumor-associated immune microenvironment. | JCI Insight | 2022 | 36107619 | PubTator, text mining | PubMed |
| Lipid Metabolic-Related Signature CYP19A1 is a Potential Biomarker for Prognosis and Immune Cell Infiltration in Gastric Cancer. | J Inflamm Res | 2022 | 36091333 | PubTator, text mining | PubMed |
| Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer. | Front Immunol | 2022 | 36090985 | PubTator, text mining | PubMed |
| Human lung-resident mucosal-associated invariant T cells are abundant, express antimicrobial proteins, and are cytokine responsive. | Commun Biol | 2022 | 36085311 | PubTator, text mining | PubMed |
| Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics. | Heliyon | 2022 | 36082331 | PubTator, text mining | PubMed |
| Paving the Way to Solid Tumors: Challenges and Strategies for Adoptively Transferred Transgenic T Cells in the Tumor Microenvironment. | Cancers (Basel) | 2022 | 36077730 | PubTator, text mining | PubMed |
| Regulation of pancreatic cancer therapy resistance by chemokines. | Semin Cancer Biol | 2022 | 36064086 | PubTator, text mining | PubMed |
| PSMB5 overexpression is correlated with tumor proliferation and poor prognosis in hepatocellular carcinoma. | FEBS Open Bio | 2022 | 36062301 | PubTator, text mining | PubMed |
| Phosphatidylinositol glycan anchor biosynthesis, class C is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma. | Front Genet | 2022 | 36061167 | PubTator, text mining | PubMed |
| TIMM13 as a prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma (SKCM). | Front Surg | 2022 | 36061054 | PubTator, text mining | PubMed |
| Bioinformatics Prediction and in vivo Verification Identify SLC7A5 as Immune Infiltration Related Biomarker in Breast Cancer. | Cancer Manag Res | 2022 | 36060214 | PubTator, text mining | PubMed |
| Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma. | Eur J Med Res | 2022 | 36045400 | PubTator, text mining | PubMed |
| LINC00511/hsa-miR-573 axis-mediated high expression of Gasdermin C associates with dismal prognosis and tumor immune infiltration of breast cancer. | Sci Rep | 2022 | 36042287 | PubTator, text mining | PubMed |
| Methylation status of TK1 correlated with immune infiltrates in prostate cancer. | Front Genet | 2022 | 36035114 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=28